The FX Series is the only laser on the market to treat chronic low back pain. Our FDA market cleared laser has been proven in a double-blind, placebo-controlled, randomized, parallel-group, multi-center clinical trial to treat this painful condition effectively. The FX Series Clinical Trial participants showed a 58% pain reduction at a 2-month follow-up evaluation and accumulative improvements at six months. The recent clearance of the FX is groundbreaking for the pain management community and the war on opioids.
For patients and physicians looking for an opioid-free alternative to chronic and acute pain; Laser therapy is proving to be a medical breakthrough with incredible results, no harmful side effects, and, most promising of all, no potential for addiction.
The FX 405 offers the addition of the 405nm violet laser. The violet laser allows physicians to broaden the conditions they cant treat widely. In addition, the violet laser has been proven as an anti-microbial & anti-bacterial modality.